PEBP1 and non-small cell lung carcinoma: For all the mixed datasets, the ROC analysis showed a high and significant AUC, meaning that the assessment of both YY1 and RKIP levels of expression might be used as novel predictive diagnostic biomarkers in NSCLC (Figure 3 and Figure 5).